![]() Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. | ![]() Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). | ||||
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2014 | Founding Date 2011 | Founding Date 1997 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Paris, FR HQ Paris, FR | Locations New York, US HQ San Diego, US | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Fangshan Qu, CN HQ | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US |
Employees | Employees 783% increase | Employees 62520% increase | Employees 908 | Employees 831 | Employees 1652% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 201.9 m | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) NT$101.9m (FY, 2020) |
Net income | Net income N/A | Net income ($137.1m) (FY, 2025) | Net income ($397.9m) (FY, 2025) | Net income N/A | Net income (NT$983.3m) (FY, 2020) |
Funding | |||||
Latest funding round | Latest funding round $ 1.1m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 150m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.1m | Total funding raised $ 119m | Total funding raised $ 1.9b | Total funding raised $ 560m | Total funding raised N/A |

Zentalis is a biopharmaceutical company.
View company
Roivant Sciences is a company that develops and commercializes medicines.
View company
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
View company
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View company